Dongbo Jiang

10PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 28, 2026
Enhancing persistence while managing cytokine release syndrome to embrace next-generation CAR-T cell therapy.

|Nov 13, 2025
Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm.

Yuanli He, Chenchen Hu, Feiming Hu

|Aug 13, 2025
IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma.

Feiming Hu, Chenchen Hu, Yuanli He

|Jan 25, 2025
TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma.

Feiming Hu, Chenchen Hu, Yuanli He

|Nov 26, 2024
Immunoreactivity Analysis of MHC-I Epitopes Derived from the Nucleocapsid Protein of SARS-CoV-2 via Computation and Vaccination.

Dongbo Jiang, Zilu Ma, Junqi Zhang

|Sep 28, 2024
Lysosome-Associated Membrane Protein Targeting Strategy Improved Immunogenicity of Glycoprotein-Based DNA Vaccine for Marburg Virus.

Xiyang Zhang, Yubo Sun, Junqi Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Baozeng Sun

3 joint publications

Shuya Yang

1 joint publications

Hao Sun

1 joint publications

Jiawei Wang